淋巴瘤的 CAR-T 细胞治疗:新场景与未来方向 Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. PubMed 2023/12/21 发表Cancers (Basel)Q2 · IF 4.8(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:CAR-T大B细胞淋巴瘤滤泡性淋巴瘤霍奇金淋巴瘤 32.0分 ★☆☆☆☆ 站内排序·非疗效